Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. - Wikidata - wikimedia - TriplyDB

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

http://www.wikidata.org/entity/Q33455505

about

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation The great escape: viral strategies to counter BST-2/tetherin The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin Rab7A is required for efficient production of infectious HIV-1 Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1 Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors The restriction factors of human immunodeficiency virus HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin BST-2/tetherin: a new component of the innate immune response to enveloped viruses Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes The role of BST-2/Tetherin in host protection and disease manifestation Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Ubiquitination-mediated regulation of interferon responses Viral Membrane Channels: Role and Function in the Virus Life Cycle Tetherin restricts productive HIV-1 cell-to-cell transmission Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles Structural insight into the mechanisms of enveloped virus tethering by tetherin Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation Mechanism of HIV-1 virion entrapment by tetherin The HIV mutation browser: a resource for human immunodeficiency virus mutagenesis and polymorphism data Immune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 Infection HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway Counteraction of the multifunctional restriction factor tetherin The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses.Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.Modulation of HIV-1-host interaction: role of the Vpu accessory protein Lack of adaptation to human tetherin in HIV-1 group O and P.

P2860

Q21089617-E1159439-2B97-4CB5-9DE9-E5E02380AC18 Q21090506-CEF9E659-BFCC-4DCD-9545-18D024B2BA8C Q21245050-088544F4-642A-4417-8F7F-E3D86F140D24 Q24294470-F5DA0286-347C-4EEE-8A6C-D4778969009F Q24296650-BD5549FD-0D51-4E74-BFBD-B0AFCF638479 Q24297949-9FAA4C3F-775A-4E16-9054-E16739B019B9 Q24306855-632B4853-CF2A-49C3-9365-8FB44716B29F Q24306898-EF87207D-BB93-4CE2-AE40-6732F00CF8D8 Q24604018-94CAC763-AF5E-4F61-B66A-AD30D2C3DCA6 Q24605108-832B3A5A-78ED-4759-A208-D7A21483AD50 Q24619066-994EEEA2-3219-436E-AB32-492406210EDD Q24629504-99B1EE54-5204-46C1-92B9-91FF2CC114FD Q24630382-8EC50EB0-E4C2-448F-BB4E-705AFAB7EE47 Q24635271-3545475D-CC3E-48ED-9BC9-785062229F89 Q24646984-12555B50-1168-4590-A215-7D5E9397918B Q26752737-3A4B143A-86A7-4173-8B0B-38759A79D649 Q26767362-933C1868-DFAC-4B6C-A511-BD615EF8A317 Q26851152-2A48C205-0494-4075-89E8-E4E1E4B17DFC Q26853323-BE3BB897-0FF0-43DE-B09D-6B6763B14670 Q27000898-86A4F216-6CCF-49C5-BB86-6A81ECED74E2 Q27314339-43D1E244-6D35-4623-9A05-C1DB0A45BED0 Q27316022-2AF9A282-05D0-4390-94DE-F45D607DD095 Q27664987-0CD876B7-9D0A-4C6C-A25F-CC95EFF5A111 Q27665937-E76BE3D6-6BA5-474A-9A64-CA74F76E4048 Q28237912-6022E4DB-D975-4B86-9E78-9813BDB60645 Q28472771-62FCDE8B-7B75-497B-9E15-AE9BC0D97529 Q28478446-A6FE1FCE-72CE-4E50-B4FC-5B1400D73E34 Q28533773-FD4FBFC0-5DE9-4AFD-ADBF-01A871C606C9 Q28534707-852C6BFC-A965-477A-B314-12FDBA0E4A99 Q28542469-18144BD6-0852-4E24-92C9-3471E8FCD67A Q28589591-30090EEE-5BCE-46DF-B174-A7E3831DE785 Q28595739-79C1A44D-78C1-483F-983F-6E6BA1702C2D Q28659945-9E492576-1E92-4C44-9DC0-1C3C5883373F Q28742774-56A49AD5-2B97-49F3-80E2-C5DDE0F8B42D Q30359547-676755B5-7754-4F92-AE9D-C431B6AABC8A Q30360141-31B45DE6-9F15-46FE-9550-6C00EB7F813E Q30376050-7E0A9116-F8C7-4DDA-8A00-B233B60AB4D6 Q30379978-9592A861-C798-4352-BEBC-83294B2BA21D Q30397761-10563F0B-A588-4ACD-9D73-70629D8A69D8 Q30407564-C32F2C9D-67BA-4B22-888A-92A0558C028F

P2860

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

http://www.wikidata.org/entity/Q33455505

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@ast

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@en

type

label

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@ast

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@en

prefLabel

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@ast

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@en

P1433

Q33455505-53EDF51D-67D8-41B6-BDB2-B43669775446

P1476

Q33455505-1BAD1D04-7FE2-4E90-8C07-8F53E79EA4B4

P2093

Q33455505-0005CF48-2AAF-4CB1-A4AE-414AF638E607

Q33455505-39E4D703-96B5-40B4-B395-676DE35AD9BF

Q33455505-46C25254-A87D-4CC8-8C5E-120812AF0852

Q33455505-4E2191BB-C24C-4C1C-8654-E8430590C755

Q33455505-57A71F2C-2B3B-491A-AD45-2B9636049668

Q33455505-7E8C3D97-72E5-4255-BB74-3AD9CEF62F43

Q33455505-A2C8BFC1-7E91-48BF-9CD9-22FFD1735A0E

Q33455505-D29C040A-BFCE-4932-8BA6-0C4690F8D6E5

Q33455505-E258A6BB-132E-4A63-AFC3-474C8874F943

P2860

Q33455505-214C3F9A-6902-4D54-9955-E1DDA34E4B2E

Q33455505-2A197C55-E0BF-4AD4-98AE-024EEB02D838

Q33455505-323BE3FE-527A-473B-8D48-9E430CB4748B

Q33455505-32C76F76-1F00-4AE1-900C-FE807EBB509C

Q33455505-35FDBF2C-7989-473A-8190-36AC08BFC914

Q33455505-36DE983E-4805-4FAD-8B20-CA3CDBF95A2A

Q33455505-370E5D8A-5B05-4A0A-8C60-27602028D01B

Q33455505-39A62F3F-ACE1-4507-BF85-FDB002556E71

Q33455505-3A9B1128-636E-467D-8CD4-839BEC62DC06

Q33455505-3E6AA206-45C3-4283-885A-884D6E3A69DE

P304

Q33455505-D90DBA3D-EF1D-44EF-A451-349AF4708BFF

P31

Q33455505-0DA1181D-9C8F-46B0-8873-372A006DBC6F

P356

Q33455505-0C2445A5-5562-4DE2-8193-16FC8E36F184

P433

Q33455505-2DA73563-CE49-439F-822A-DFDB1485A3F6

P478

Q33455505-FECE4D15-1063-4F6B-B83C-0A0FDD2905D1

P50

Q33455505-5423CE7A-535E-4B22-8FB4-C5FD15ABFAFC

P577

Q33455505-C8364178-7036-46D6-9287-3B9714792A7C

P5875

Q33455505-85A86E24-1DD0-4BC3-889A-B7F08E7681F5

P698

Q33455505-ED2AB085-B85A-4A47-AAF1-8BFE818200E8

P932

Q33455505-A457E045-1F00-469B-BBBE-724088F1B904

P356

JOURNAL.PPAT.1000450

P1433

P1476

Vpu antagonizes BST-2-mediated ...... nd endo-lysosomal trafficking.

@en

P2093

Autumn Ruiz

http://www.w3.org/2001/XMLSchema#string

Chris Katsura

http://www.w3.org/2001/XMLSchema#string

David Lau

http://www.w3.org/2001/XMLSchema#string

Edward B Stephens

http://www.w3.org/2001/XMLSchema#string

John C Guatelli

http://www.w3.org/2001/XMLSchema#string

Katie Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Mark A Skasko

http://www.w3.org/2001/XMLSchema#string

Richard Benarous

http://www.w3.org/2001/XMLSchema#string

Richard S Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

A family of mammalian F-box proteins

V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway

SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein

Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments

Inhibition of Lassa and Marburg virus production by tetherin

beta-TrCP mediates the signal-induced ubiquitination of IkappaBbeta

P304

e1000450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000450

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Florence Margottin-Goguet

P577

2009-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26249975

http://www.w3.org/2001/XMLSchema#string

P698

19478868

http://www.w3.org/2001/XMLSchema#string

P932

2679223

http://www.w3.org/2001/XMLSchema#string